Literature DB >> 24679443

Polymorphism in THBS1 gene is associated with post-refractive surgery chronic ocular surface inflammation.

Laura Contreras-Ruiz1, Denise S Ryan2, Rose K Sia2, Kraig S Bower3, Darlene A Dartt4, Sharmila Masli5.   

Abstract

PURPOSE: To determine the association of single nucleotide polymorphisms (SNPs) of the thrombospondin 1 (THBS1) gene with development of chronic ocular surface inflammation (keratoconjunctivitis) after refractive surgery.
DESIGN: Retrospective cohort study. PARTICIPANTS: Active duty U.S. Army soldiers (n = 143) who opted for refractive surgery.
METHODS: Conjunctival impression cytology samples collected from participants before the surgery were used to harvest DNA for genotyping 5 THBS1 SNPs (rs1478604, rs2228262, rs2292305, rs2228262, and rs3743125) using the Sequenom iPLEX Gold platform (Sequenom, San Diego, CA). Samples collected after surgery were used to harvest RNA for gene expression analysis by real-time polymerase chain reaction (PCR). Participants were followed for 1 year after surgery to monitor the status of keratoconjunctivitis. MAIN OUTCOME MEASURES: Genetic basis of the development of chronic keratoconjunctivitis after refractive surgery.
RESULTS: Carriers of minor alleles of 3 SNPs each were found to be more susceptible to developing chronic keratoconjunctivitis (rs1478604: odds ratio [OR], 2.5; 95% confidence interval [CI], 1.41-4.47; P = 2.5 × 10(-3); rs2228262 and rs2292305: OR, 1.9; 95% CI, 1.05-3.51; P = 4.8 × 10(-2)). Carriers of the rs1478604 minor allele expressed significantly reduced levels of thrombospondin 1 (TSP1) (P = 0.042) and increased levels of an inflammatory cytokine associated with keratoconjunctivitis, interleukin-1β (P = 0.025), in their ocular surface epithelial cells compared with homozygous major allele controls.
CONCLUSIONS: Genetic variation in the THBS1 gene that results in decreased expression of the encoded glycoprotein TSP1 in ocular surface epithelial cells significantly increases the susceptibility to develop chronic ocular surface inflammation after refractive surgery. Further investigation of THBS1 SNPs in a larger sample size is warranted.
Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24679443      PMCID: PMC4197802          DOI: 10.1016/j.ophtha.2014.01.033

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  45 in total

1.  Inference of population structure using multilocus genotype data.

Authors:  J K Pritchard; M Stephens; P Donnelly
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

2.  Control of confounding of genetic associations in stratified populations.

Authors:  Clive J Hoggart; Eteban J Parra; Mark D Shriver; Carolina Bonilla; Rick A Kittles; David G Clayton; Paul M McKeigue
Journal:  Am J Hum Genet       Date:  2003-06       Impact factor: 11.025

3.  Incidence of dry eye in an older population.

Authors:  Scot E Moss; Ronald Klein; Barbara E K Klein
Journal:  Arch Ophthalmol       Date:  2004-03

4.  The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size.

Authors:  Jeffrey I Zwicker; Flora Peyvandi; Roberta Palla; Rossana Lombardi; Maria Teresa Canciani; Andrea Cairo; Diego Ardissino; Luisa Bernardinelli; Kenneth A Bauer; Jack Lawler; Pier Mannucci
Journal:  Blood       Date:  2006-05-09       Impact factor: 22.113

5.  Unique distribution of thrombospondin-1 in human ocular surface epithelium.

Authors:  Eiichi Sekiyama; Takahiro Nakamura; Leanne J Cooper; Satoshi Kawasaki; Junji Hamuro; Nigel J Fullwood; Shigeru Kinoshita
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

6.  A mouse model of keratoconjunctivitis sicca.

Authors:  Dilek Dursun; Min Wang; Dagoberto Monroy; De-Quan Li; Balakrishna L Lokeshwar; Michael E Stern; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-03       Impact factor: 4.799

7.  A polymorphism in thrombospondin-1 associated with familial premature coronary artery disease alters Ca2+ binding.

Authors:  Blue-leaf A Hannah; Tina M Misenheimer; Michelle M Pranghofer; Deane F Mosher
Journal:  J Biol Chem       Date:  2004-09-28       Impact factor: 5.157

8.  The incidence and risk factors for developing dry eye after myopic LASIK.

Authors:  Cintia S De Paiva; Zhuo Chen; Douglas D Koch; M Bowes Hamill; Francis K Manuel; Sohela S Hassan; Kirk R Wilhelmus; Stephen C Pflugfelder
Journal:  Am J Ophthalmol       Date:  2006-03       Impact factor: 5.258

9.  Desiccating stress induces T cell-mediated Sjögren's Syndrome-like lacrimal keratoconjunctivitis.

Authors:  Jerry Y Niederkorn; Michael E Stern; Stephen C Pflugfelder; Cintia S De Paiva; Rosa M Corrales; Jianping Gao; Karyn Siemasko
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

Review 10.  Dry eye as a mucosal autoimmune disease.

Authors:  Michael E Stern; Chris S Schaumburg; Stephen C Pflugfelder
Journal:  Int Rev Immunol       Date:  2013-02       Impact factor: 5.311

View more
  17 in total

Review 1.  Thrombospondin-1 in ocular surface health and disease.

Authors:  William Foulsham; Thomas H Dohlman; Sharad K Mittal; Yukako Taketani; Rohan Bir Singh; Sharmila Masli; Reza Dana
Journal:  Ocul Surf       Date:  2019-06-05       Impact factor: 5.033

Review 2.  Advancements in Understanding Immunogenicity of Biotherapeutics in the Intraocular Space.

Authors:  Eric Wakshull; Valerie Quarmby; Hanns-Christian Mahler; Hongwen Rivers; Dhananjay Jere; Meg Ramos; Piotr Szczesny; Karoline Bechtold-Peters; Sharmila Masli; Swati Gupta
Journal:  AAPS J       Date:  2017-08-09       Impact factor: 4.009

3.  Secondary allergic T cell responses are regulated by dendritic cell-derived thrombospondin-1 in the setting of allergic eye disease.

Authors:  R E Smith; N J Reyes; P Khandelwal; S L Schlereth; H S Lee; S Masli; D R Saban
Journal:  J Leukoc Biol       Date:  2016-02-08       Impact factor: 4.962

4.  Thrombospondin-derived peptide attenuates Sjögren's syndrome-associated ocular surface inflammation in mice.

Authors:  L Contreras Ruiz; F A Mir; B Turpie; S Masli
Journal:  Clin Exp Immunol       Date:  2017-01-31       Impact factor: 4.330

5.  Alteration in cellular turnover and progenitor cell population in lacrimal glands from thrombospondin 1-/- mice, a model of dry eye.

Authors:  Marie A Shatos; Robin R Hodges; Masahiro Morinaga; David E McNay; Rakibul Islam; Sumit Bhattacharya; Dayu Li; Bruce Turpie; Helen P Makarenkova; Sharmila Masli; Tor P Utheim; Darlene A Dartt
Journal:  Exp Eye Res       Date:  2016-09-30       Impact factor: 3.467

Review 6.  Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation.

Authors:  Sharmila Masli; Nader Sheibani; Claus Cursiefen; James Zieske
Journal:  Curr Eye Res       Date:  2014-02-21       Impact factor: 2.424

7.  Inflammatory Cytokine-Mediated Regulation of Thrombospondin-1 and CD36 in Conjunctival Cells.

Authors:  Laura Soriano-Romaní; Laura Contreras-Ruiz; Laura García-Posadas; Antonio López-García; Sharmila Masli; Yolanda Diebold
Journal:  J Ocul Pharmacol Ther       Date:  2015-07-08       Impact factor: 2.671

8.  Thrombospondin-1-dependent immune regulation by transforming growth factor-β2-exposed antigen-presenting cells.

Authors:  Fayaz Ahmad Mir; Laura Contreras-Ruiz; Sharmila Masli
Journal:  Immunology       Date:  2015-10-12       Impact factor: 7.397

9.  THBS1 (thrombospondin-1).

Authors:  Jeffrey S Isenberg; David D Roberts
Journal:  Atlas Genet Cytogenet Oncol Haematol       Date:  2020

10.  Expression of thrombospondin-1 in conjunctival squamous cell carcinoma is correlated to the Ki67 index and associated with progression-free survival.

Authors:  Mizuki Tagami; Anna Kakehashi; Atsushi Sakai; Norihiko Misawa; Atsuko Katsuyama-Yoshikawa; Hideki Wanibuchi; Atsushi Azumi; Shigeru Honda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-05-29       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.